"During my ophthalmological practice macular diseases always have been my special concern, especially Age-related Macular Degeneration. However, I had to fi nd again and again that patients evaluate treatment outcomes differently from us doctors. While a patient maintains their ability to focus and orientate themself, they are usually not able to read anymore. These observations finally led to the development of our Macula Lens in cooperation with the Hungarian company Medicontur Medical Engineering." Prof. Gábor B. Scharioth
WHAT IS SML?
SML - THE 'MAGNIFYING GLASS' IN THE EYE
SML - the Scharioth Macula Lens - is an intraocular lens with a special central optic providing a high addition of +10 Diopters, developed by Prof. Gábor B. Scharioth.
SML - THE MAGNIFYIER IN THE EYE
- Easy and safe surgery
- Independent from lens status
- Sufficient magnification
- No reduction of visual field
- Distance vision not affected
THE SML ACTS LIKE A MAGNIFIER IN THE EYE
- enables patients to read again and distinguish small details
- does not affect their distance vision
- will not influence their regular eye-checkup
NO MORE MAGNIFYING GLASSES - JUST FREE HANDS
Mode of Action: MAGNIFICATION
For is the SML recommended for?
The SML has been developed for patients with MACULAR DEGENERATION – specifically DRY AMD, but it might be helpful for patients with other macular diseases, for example myopic maculopathy, diabetic maculopathy or hereditary retinal diseases.
Zooming in on Macular Degeneration
WHAT IS MACULAR DEGENERATION?
The term macular degeneration is used synonymously for a number of diseases aff ecting the 'point of sharpest vision', the macula.
There are different types of Macular Degeneration:
- Age-related macular degeneration
- Diabetic maculopathy
- Myopic macular degeneration
- And many others
Age-related macular degeneration (AMD) is the most common cause of vision loss in those aged over 55.
For reasons that are unclear AMD tends to be more common in women than men. People of Caucasian or Chinese ethnicity are more likely to get AMD than other ethnic groups. As would be expected from its name, age is one of the most important risk factors for AMD. It is estimated that around 1 in 10 people aged between 55–64 years have AMD. This ratio rises to 1 in 2 people aged 85 or over.
WHAT IS THE MACULA?
Macula: the few square millimeters wide area of sharpest vision. The macula is essential for central vision. AMD comes with deposits that occur at an early stage of the disease, usually unnoticed by the patient. In the further course of the disease there is a degradation of the retinal tissue
in the macula, resulting in a more or less reduced visual performance. This first form is referred to as dry macular degeneration.
Alternatively, blood vessel membranes can grow under the retina in the course of the disease. These membranes easily leak or rupture, causing fluid retention (edema) or bleeding. This latter form is referred to as wet macular degeneration.
Age-Related Macular Degeneration
Age-related macular degeneration (AMD) is an eye condition that occurs when cells in the macula degenerate. The macula, the most sensitive part of retina, can not function as it should normally, which leads to deterioration of central vision.
With AMD, dark areas may appear in the central vision
Damage to the macula affects the central vision, which is needed for reading, writing, driving, recognizing people's faces, and doing other fine tasks. It also affects color vision, and leads to lower contrast sensitivity.
- The SML implantation is performed under sterile conditions.
- For high precision the surgery is performed under a microscope.
- The SML, just like any other foldable intraocular lens, will unfold during implantation and can easily be placed into the ciliary sulcus, the space in-between the primary artificial intraocular lens and the Iris (the colorful part of the eye).
- A suture is not required, since the wound closes by itself.
- The SML implantation takes only 15 minutes.
- Surgery may be performed simultaneously with cataract surgery, or years later - the SML may be implanted at any time.
SML: Microscopic Magnifi er in the EYE
Do not forget: WITH THE SML TO THE PATIENT MUST READ FROM A DISTANCE OF APPROX. 15 cm
READ THE STORY OF THE FIRST PATIENT IMPLANTED WITH THE SML
Mr. E. Beckmann was the first patient - worldwide - to be implanted with the SML.
Six months after SML implantation Mr. Beckmann described his life as follows:
“My vision was getting worse and worse over the years and I had to obtain so many different low vision aids. Recently, before the surgery I had to rely on a very strong magnifier and a screen reader. It made my life very limited. Today, I can read small print and take a closer look at delicate woodwork.”
Patients: Talk to your doctor.
Ask for the opportunity to be implanted with an SML.
Patient: The SML might significantly improve your reading abilities. The SML might allow you to enjoy your hobbies again, improving the quality of your life.